Allogene Therapeutics

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Artiva Biotherapeutics

The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.

Caribou Biosciences

This biopharmaceutical company develops genome-edited allogeneic cell therapies to treat patients with hematologic malignancies and other human diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Catamaran Bio

This biotechnology company develops off-the-shelf allogeneic cell therapies for patients with solid tumours and other cancers using natural killer cells.

Appia Bio

This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.

Autolus

Autolus develops programmed T-cell therapies for patients with cancer and autoimmune diseases, including an approved treatment for adult B-cell acute lymphoblastic leukaemia.

Adicet Bio

Adicet Bio develops allogeneic gamma delta T cell therapies for patients with autoimmune diseases and cancer.